Enveric Biosciences, Inc. (ENVB) — Institutional Holders, Q2 2026
25 institutional investment managers reported a ENVB position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $737.7K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
ENVB in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Sio Capital ManagementNew · +180,000 sh+$248.4K
- Ikarian CapitalNew · +100,002 sh+$138.0K
- RENAISSANCE TECHNOLOGIESNew · +32,058 sh+$44.2K
- ARMISTICE CAPITALNew · +32,000 sh+$44.2K
- BOOTHBAY FUND MANAGEMENTNew · +30,142 sh+$41.6K
Biggest sellers
- GEODE CAPITAL MANAGEMENTTrimmed · -20,355 sh-$28.1K
- UBS Group AGTrimmed · -3,411 sh-$4.7K
- GROUP ONE TRADING, L.P.Sold out · -1 sh-$1.00
ENVB 13F holders ranked 1–25 of 25
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Sio Capital Management#1 · 180,000 sh | 180,000 | $248.4K | 0.04% | New |
| 2 | Ikarian Capital#2 · 100,002 sh | 100,002 | $138.0K | 0.01% | New |
| 3 | AdvisorShares Investments#3 · 35,417 sh | 35,417 | $48.9K | <0.01% | +108.7% |
| 4 | RENAISSANCE TECHNOLOGIES#4 · 32,058 sh | 32,058 | $44.2K | <0.01% | New |
| 5 | ARMISTICE CAPITAL#5 · 32,000 sh | 32,000 | $44.2K | <0.01% | New |
| 6 | BOOTHBAY FUND MANAGEMENT#6 · 30,142 sh | 30,142 | $41.6K | <0.01% | New |
| 7 | XTX Topco Ltd#7 · 18,990 sh | 18,990 | $26.2K | <0.01% | New |
| 8 | StoneX Group#8 · 11,814 sh | 11,814 | $21.9K | <0.01% | New |
| 9 | HRT FINANCIAL#9 · 15,458 sh | 15,458 | $21.0K | <0.01% | New |
| 10 | VANGUARD CAPITAL MANAGEMENT#10 · 14,912 sh | 14,912 | $20.6K | 0.00% | New |
| 11 | CITADEL ADVISORS#11 · 13,965 sh | 13,965 | $19.3K | 0.00% | New |
| 12 | GEODE CAPITAL MANAGEMENT#12 · 11,794 sh | 11,794 | $16.3K | 0.00% | -63.3% |
| 13 | Virtu Financial#13 · 10,690 sh | 10,690 | $15.0K | <0.01% | New |
| 14 | MORGAN STANLEY#14 · 10,733 sh | 10,733 | $14.8K | 0.00% | New |
| 15 | Tower Research Capital (TRC)#15 · 4,984 sh | 4,984 | $6.9K | <0.01% | +351.9% |
| 16 | Farther Finance Advisors#16 · 3,000 sh | 3,000 | $4.1K | — | New |
| 17 | SBI Securities , Ltd.#17 · 2,676 sh | 2,676 | $3.7K | — | +3124.1% |
| 18 | JONES FINANCIAL COMPANIES LLLP#18 · 1,000 sh | 1,000 | $1.4K | 0.00% | 0.0% |
| 19 | Integrated Wealth Concepts#19 · 702 sh | 702 | $969.00 | 0.00% | New |
| 20 | UBS Group AG#20 · 201 sh | 201 | $277.00 | 0.00% | -94.4% |
| 21 | BlackRock#21 · 51 sh | 51 | $70.00 | 0.00% | 0.0% |
| 22 | OSAIC#22 · 1 sh | 1 | $1.00 | 0.00% | New |
| 23 | WELLS FARGO & COMPANY#23 · 1 sh | 1 | $1.00 | 0.00% | 0.0% |
| 24 | DANSKE BANK A/S#24 · 1 sh | 1 | $1.00 | 0.00% | 0.0% |
| 25 | NATIONAL BANK OF CANADA#25 · 1 sh | 1 | $1.00 | 0.00% | 0.0% |
Funds that sold out of ENVB in Q2 2026 (1)
Held ENVB at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| GROUP ONE TRADING, L.P.1 sh | 1 | $2.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.